Thoughts on Leadership and Trends in Healthcare in America
The Future of Health Care: Becoming Strategic Partners
In an article published in DOTmed Business News, August Calhoun, PhD, Senior Vice President of North America Services, explains how a partnership with Siemens Healthineers focuses on improving patient care and bringing clear, fast and flexible results for the customer.
“Question Marks,” “Candidates,” and “Stars”: An Evidence Value Matrix for Diagnostic Imaging
In an article co-authored by Richard Frank, MD, PhD, and published in the Journal of the American College of Radiology titled “The Evidence Value Matrix for Diagnostic Imaging”, a proposed two-dimensional matrix allows classification of imaging devices into three distinct categories from which specific strategies for evidence and value generation can be developed.
The Future of Health Care: Molecular Imaging Targets the Prostate
“In the past decade, the molecular imaging community saw only limited introduction of new radiotracers for positron emission tomography (PET) imaging. Now, however, we look with great anticipation to a new generation of tracers that are increasingly demonstrating value in the assessment of recurrent prostate cancer.” Read more from James Williams, PhD, head of Siemens Healthineers Molecular Imaging business.
Happy Father’s Day from Siemens Healthineers
Read a special message from David Pacitti, President of Siemens Healthineers North America.
Imaging's Rise in Cardiology: Its Impact on Procedure Rooms and Equipment Vendors
Minimally invasive structural heart procedures are surging in the U.S., with medical imaging playing a substantial role in the guidance of these procedures. How is this trend impacting the physical space in which you perform cardiovascular procedures? David Pacitti, Head of Siemens Healthcare North America, discusses the modern image-guided procedure room – the equipment it contains, and the physicians who will utilize it.
Imaging: Cardio Care’s Future
“…A brave new world is dawning in cardiovascular repair – one illuminated by information that only medical imaging can provide.” Read more in an article by David Pacitti, Head of Siemens Healthcare North America, published in DOTmed Healthcare Business News.
What is Disrupting the Health Industry? Challenges and Opportunities
This year at the HIMSS 2016 Annual Conference and Exhibition in Las Vegas, the medical community is at the forefront of designing a system of new value networks in healthcare that disrupt old business models. Read insights from David Pacitti, Head of Siemens Healthcare North America.
Accurate Diagnosis: The Conduit for Value-Based Care
“Our changing healthcare system requires all of us to change along with it. Just as medical device manufacturers have to adjust to increased scrutiny of value, so do hospitals, physicians and health IT manufacturers need to modify based on the new environment.” Read more in an article by David Fisher, Head of Global Policy and Government Affairs at Siemens Healthcare.
Q&A: Different Perspective on Imaging and Healthcare Reform
David Fisher, Head of Global Policy and Government Affairs, spoke with Diagnostic Imaging about healthcare legislation.
100 Years of Radiology
David Pacitti, Head of Siemens Healthcare North America, looks back on 100 years of radiology.
Siemens Clinical Lab Cancer Diagnostics Research: InsideView Profile Feature in Nature
Nature talked with Trevor Hawkins, head of the Siemens Clinical Laboratory (SCL), and Michael Pugia, a principle key expert in strategic innovation, about the SCL, particularly with regards to circulating tumor cells detection technology.
How to Save Healthcare a Bundle
"The single most important issue U.S. healthcare providers must address today is the tremendous gap between the amount (and subsequent cost) of care provided each year and the overall health of our patients.” Read more from Greg Sorensen, MD, on LinkedIn.
“While multiple countries across the globe struggle with limited access to proper healthcare, we in the U.S. currently have the opposite problem, what I call Marshmallow Medicine.” Read more from Greg Sorensen, MD, in his latest LinkedIn post.
Two Events, One Lesson: Increase Federal Support for Cancer Research
In a blog posted in the Huffington Post, Gregory Sorensen, MD, writes about the documentary "Cancer: The Emperor of All Maladies" and the importance of federal funding of cancer research.
White Paper: Improving Quality and Productivity in Healthcare
Gregory Sorensen, MD, President and CEO, Siemens Healthcare North America, explores ways to boost quality and productivity in healthcare by reducing variability and efficiently increasing output.
What Does it Take to Lead the Healthcare Industry of Tomorrow?
Read this and other insights from Gregory Sorensen, MD, by following his posts on LinkedIn.
Moving Toward Improved Lung Cancer Detection
A study1 found that Low Dose Computed Tomography (LDCT) screening for lung cancer is twice as efficient for patients over 65 as it is for patients under 65. Siemens is pleased that Medicare beneficiaries soon will be covered for this screening tool.
How Can Healthcare Providers Be More Efficient without Cutting Costs?
Richard Frank, MD, PhD, Chief Medical Officer, Siemens Healthcare, talks to The Doctor’s Channel.
How Will Payment Reform Impact Diagnostic Services?
David Fisher, VP, Siemens Healthcare Policy & Strategy, considers how payment reform will affect imaging services in a new DOTmed daily news column.
White Paper: Diagnosis, Misdiagnosis, and the Value of Knowing
Gregory Sorensen, MD, President and CEO, Siemens Healthcare North America, explores the impact of early and accurate diagnosis.
Gregory Sorensen, MD, president and CEO, Siemens Healthcare, North America, reflects in the Sacramento Bee on the biomedical breakthroughs happening in the United States and the significance of federal funding that makes so much of critical treatment possible.
Imaging’s Role in Cancer Research
“From diagnosing disease at its earliest and most curable stage to ensuring cancer therapies are working, medical imaging has given researchers and physicians unprecedented insight into how disease affects the human body.”
Dr. Gregory Sorensen featured as guest contributor on HBR Blog Network
"It is in the first 15 minutes of a medical encounter...that up to half of all medical costs are set in motion." Read a blog post by Gregory Sorensen, MD, President and CEO, Siemens Healthcare North America, To Cut Health Costs, Focus on the First Minutes of Care, and share your thoughts in the Comments section.
Companion Diagnostics: Making Drug Delivery Personal
“As a patient-centric shift continues to sweep our healthcare system, pharmaceutical companies are increasingly seeing the value of targeting treatments to specific patient populations, making the therapy more personal,” says Trevor Hawkins, SVP, Innovation and Business Development for Siemens Healthcare Diagnostics, in DDN NEWS.
Companion Diagnostics: Paving the Way for Personalized Medicine
Companion diagnostics is paving the way for personalized medicine—making it possible for treatment to be precisely tailored to the patient, even to his or her genetic profile. An interview with Trevor Hawkins, SVP, Innovation and Business Development for Siemens Healthcare Diagnostics, published in News Medical.
Ending the Stigma
With all the innovative treatments developed over the last two decades, lung cancer's five-year survival rate is still only 16 percent -- a mere three percent above where it was almost 40 years ago, when the "War on Cancer" was launched. Read more in a blog entry by Gregory Sorensen, MD, and Laurie Fenton Ambrose of the Lung Cancer Alliance.
Medical device tax would thwart innovation
“Every day, America’s medical technology community gets up and goes to work, focused on improving the lives of patients throughout the world. Whether manufacturing pacemakers, CT scanners or catheters, our passion for innovation and ingenuity is why this proud American industry continues to lead the world in these challenging times.”
White Paper: Integrated and Affordable Coordinated Care in the U.S.: How Do We Get There?
The U.S. is known for providing world-class care, particularly for its seriously ill patients. Unfortunately, the U.S. is also known for delivering both acute and routine care at skyrocketing costs. Read a white paper by Gregory Sorensen, MD, president and CEO, Siemens Healthcare, North America.
The Medical Device Excise Tax — Over before It Begins?
“Policies should be aimed at encouraging, not discouraging, society to put resources into improved diagnosis.” Read a letter to the editor by Gregory Sorensen, MD, published in The New England Journal of Medicine.
Gregory Sorensen: The White House Brain Initiative Hits a Tax Hurdle
“While the president launches an exciting initiative to map the brain, a new tax hurts the very innovation it seeks.” Read more of this opinion piece published in The Wall Street Journal.
Innovations in Healthcare Technology – Emtech MIT Conference
Gregory Sorensen, MD, President and Chief Executive Officer, Siemens Healthcare North America, discusses the company's corporate innovation culture, which helps Siemens anticipate trends in healthcare technology. He also focuses on how Siemens is engineering tools to help improve clinical processes.
1National Lung Screening Trial Findings by Age; Medicare-eligible Versus Under-65 Population, Annals of Internal Medicine, 2014 Nov 4.